While the demand for biological agents is increasing, due to high prices and less efficient production systems such as microbial, insect, animal cells and transgenic animals, plant molecular farming is increasing. It offers a promising way to produce biologically active substances for vaccines and reagents due to its ease of cultivation, increased safety of recombinant proteins, the ability to modify eukaryotic proteins, the ability to produce plant and animal viral proteins that assemble themselves into virus nanoparticles, and the possibility of affordable production on a large scale.
|
